Immunic Statistics
NASDAQ: IMUXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.99-0.40 (-5.41%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Immunic by the numbers
Immunic has a market capitalization of $111.0 million based on 15.88M shares outstanding. With trailing EPS of $-3.53, Immunic is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.8% below its 50-day average and 39.7% below its 200-day average.
Average daily trading volume is 343.44K shares, or about $2.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMUX valuation vs. peer median
| Metric | IMUX | Peer median | Difference |
|---|---|---|---|
| Market cap | $111.01M | $108.89M | +2% |
| Avg. volume | 343.44K | 334.55K | +3% |
Peer median across 8 companies: OKUR, MENS, SPRB, BGM, AKBA, ADAG, GNLX, FHTX.
Valuation
- Market cap
- $111.01M
- EPS (TTM)
- $-3.53
- Shares outstanding
- 15.88M
Price and trading
- Previous close
- 7.39
- Open
- 7.31
- Day range
- 6.97 – 7.56
- 52-week range
- 5.06 – 17.43
- 52-week change
- +1.90%
- Beta
- —
- Volume
- 295.91K
- Average volume
- 343.44K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 111.01M
- Forward Pe
- -2.93
- Eps
- -3.53
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.43
- Week52 Low
- 5.06
- Avg Volume
- 343.44K
- Shares Outstanding
- 15.88M
- Ma50
- 8.20
- Ma200
- 11.59
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -59.90%
- Pct From52w Low
- 38.14%